Jasper Therapeutics, Inc. announced the appointment of two seasoned pharma industry executives to its regulatory affairs, quality and clinical operations leadership teams. Patricia Carlos joins Jasper as the company's Senior Vice President of Regulatory Affairs and Quality, and Annette Marcantonio was appointed as Vice President of Clinical Operations. Patricia Carlos has over 25 years of experience in the biotech and pharmaceutical industry, with a proven track record of success in driving global strategy, regulatory affairs, and strategic partnerships. Her expertise spans early development through approval and post-marketing in multiple therapeutic areas.

Prior to joining Jasper, she was Chief Regulatory, Quality and Safety Officer at Agenus, an immuno-oncology company. Previously, she served as Senior Vice President of Regulatory and Quality at Arcus Biosciences, where she built out the Regulatory, Quality and Safety functions and led the global regulatory strategy. Prior to Arcus, Patty held leadership roles at Bellicum Pharmaceuticals, BeiGene, Medivation-Pfizer, Gilead Sciences, and Bayer.

Patricia received her bachelor's degree from Memorial University of Newfoundland. Annette Marcantonio has spent more than 30 years in senior clinical operations and development roles, leading large-scale clinical programs in complicated and novel therapeutic areas. Prior to joining Jasper, she served as VP of Clinical Operations at Pacylex Pharmaceuticals.

Previously, she served as Vice-President of Clinical Affairs at Neurogastrx, where she successfully progressed the NG101 program in Gastroparesis. Prior to Neurogastrx, she served as Vice-President of Clinical Operations at Aimmune, where she was a key figure in designing the clinical development program and implemented and managed the studies leading to the approval of the first-in-class peanut allergy treatment Palforzia. At prior companies, she was a key participant in the filings of several US and EU marketing applications and held key leadership positions in programs that directly contributed to successful product approvals and label expansions for multiple drugs and biologics.

Annette received her bachelor's degree from Loyola-Marymount University.